Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes
Get Live Data
1.325    0.00 (0.00%)
Bid:
1.25
Ask:
1.40
Spread: 0.15 (12.00%)
Market Cap: £21.27m
GDR Live PriceLast checked at - London Stock Exchange

Intraday Genedrive Share Chart

Holding(s) in Company

17 Jun 2024 16:41

RNS Number : 7581S
Genedrive PLC
17 June 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00B1VKB244

Issuer Name

GENEDRIVE PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

Peel Hunt LLP

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

14-Jun-2024

6. Date on which Issuer notified

17-Jun-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

18.852048

0.000000

18.852048

102393291

Position of previous notification (if applicable)

19.090738

0.000000

19.090738

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00B1VKB244

102393291

0

18.852048

0.000000

Sub Total 8.A

102393291

18.852048%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

1. Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

 

12. Date of Completion

17-Jun-2024

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFSERIIDLIS
Date   Source Headline
5th Jun 20267:00 amRNSReceipt of R&D tax credit
1st Jun 20267:00 amRNSBlock Listing Returns
26th May 20267:00 amRNSBoard Changes
6th May 202611:56 amRNSHolding(s) in Company
5th May 20267:00 amRNSSussex NHS Trust transitions MT-RNR1 test to BAU
21st Apr 20267:00 amRNSNHS England commercial strategy for MT-RNR1
20th Apr 20267:00 amRNS-RInteractive Investor Hub Updates
16th Apr 20267:00 amRNSCYP2C19 kit implemented in North Bristol NHS Trust
30th Mar 20267:00 amRNSInterim Results to 31 December 2025
12th Mar 20269:52 amRNSHolding(s) in Company
12th Mar 20267:00 amRNSHolding(s) in Company
12th Mar 20267:00 amRNSHolding(s) in Company
11th Mar 20263:22 pmRNSHolding(s) in Company
11th Mar 20263:22 pmRNSHolding(s) in Company
9th Mar 202611:29 amRNSResult of General Meeting
9th Mar 20267:00 amRNSResult of Open Offer and Additional Subscriptions
24th Feb 20262:32 pmRNSHolding(s) in Company
24th Feb 202612:05 pmRNSHolding(s) in Company
19th Feb 20267:00 amRNSPublication of circular, notice of GM & timetable
13th Feb 20264:22 pmRNSCompletion of Placing
13th Feb 20262:04 pmRNSProposed Direct Subscription to raise up to £3.5m
6th Feb 20269:50 amRNSHolding(s) in Company
3rd Feb 202610:59 amRNSHolding(s) in Company
27th Jan 20262:18 pmRNSHolding(s) in Company
19th Jan 20263:01 pmRNSProposed equity raise of up to £6.0 million
31st Dec 202511:44 amRNSResult of AGM
31st Dec 202511:44 amRNSResult of AGM
18th Dec 20257:00 amRNSScotland NHS “test of change” pilot programme
11th Dec 20259:00 amRNSNew interactive investor hub
9th Dec 20253:45 pmRNSAgreement of Shareholder Loan
8th Dec 20254:00 pmRNSAnnual Report and Accounts and date of AGM
5th Dec 20257:00 amRNSFinal Results
3rd Dec 20257:00 amRNSNotice of Results
1st Dec 20253:19 pmRNSBlock Listing Returns
1st Dec 20257:00 amRNSResults presented re. NHS CYP2C19 Genotype Testing
27th Nov 202510:09 amRNSNHS implementation guide published for CYP2C19
26th Nov 20257:00 amRNSScotland national roll-out of MT-RNR1 ID Kit
19th Nov 20257:00 amRNSFurther re Shareholder Loan
4th Nov 20257:00 amRNSMT-RNR1 ID Kit in Dublin’s Rotunda Hospital
31st Oct 20257:00 amRNSPotential Shareholder Loan
29th Oct 20254:35 pmRNSHolding(s) in Company
28th Oct 20257:00 amRNSMOU with Kingdom of Saudi Arabia for MT-RNR1 ID
24th Oct 20254:30 pmRNSApplication for Listing & Total Voting Rights
15th Oct 202510:49 amRNSResult of General Meeting
10th Oct 20251:32 pmRNSHolding(s) in Company
10th Oct 20251:31 pmRNSHolding(s) in Company
10th Oct 20259:00 amRNSHolding(s) in Company
9th Oct 202510:23 amRNSFurther re Equity Financing
6th Oct 20257:00 amRNSFurther re Equity Financing
2nd Oct 20256:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.